Trinity Biotech Gross Margin 2010-2023 | TRIB
Current and historical gross margin for Trinity Biotech (TRIB) over the last 10 years. The current gross profit margin for Trinity Biotech as of September 30, 2023 is %.
| Trinity Biotech Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-09-30 | $0.07B | $0.03B | 34.72% |
| 2023-06-30 | $0.07B | $0.02B | 28.77% |
| 2023-03-31 | $0.07B | $0.02B | 29.73% |
| 2022-12-31 | $0.08B | $0.02B | 29.33% |
| 2022-09-30 | $0.07B | $0.02B | 28.36% |
| 2022-06-30 | $0.07B | $0.03B | 38.36% |
| 2022-03-31 | $0.08B | $0.03B | 39.29% |
| 2021-12-31 | $0.09B | $0.04B | 40.43% |
| 2021-09-30 | $0.11B | $0.05B | 43.93% |
| 2021-06-30 | $0.12B | $0.06B | 47.01% |
| 2021-03-31 | $0.11B | $0.05B | 47.66% |
| 2020-12-31 | $0.10B | $0.05B | 48.04% |
| 2020-09-30 | $0.09B | $0.04B | 46.67% |
| 2020-06-30 | $0.08B | $0.04B | 42.17% |
| 2020-03-31 | $0.09B | $0.04B | 41.57% |
| 2019-12-31 | $0.09B | $0.04B | 41.11% |
| 2019-09-30 | $0.09B | $0.04B | 40.43% |
| 2019-06-30 | $0.09B | $0.04B | 40.86% |
| 2019-03-31 | $0.10B | $0.04B | 41.67% |
| 2018-12-31 | $0.10B | $0.04B | 41.84% |
| 2018-09-30 | $0.10B | $0.04B | 41.84% |
| 2018-06-30 | $0.10B | $0.04B | 42.00% |
| 2018-03-31 | $0.10B | $0.04B | 42.00% |
| 2017-12-31 | $0.10B | $0.04B | 42.00% |
| 2017-09-30 | $0.10B | $0.04B | 42.42% |
| 2017-06-30 | $0.10B | $0.04B | 43.43% |
| 2017-03-31 | $0.10B | $0.04B | 44.00% |
| 2016-12-31 | $0.10B | $0.04B | 44.00% |
| 2016-09-30 | $0.10B | $0.05B | 44.55% |
| 2016-06-30 | $0.10B | $0.05B | 44.55% |
| 2016-03-31 | $0.10B | $0.04B | 44.44% |
| 2015-12-31 | $0.10B | $0.05B | 46.00% |
| 2015-09-30 | $0.10B | $0.05B | 46.08% |
| 2015-06-30 | $0.10B | $0.05B | 46.60% |
| 2015-03-31 | $0.11B | $0.05B | 47.62% |
| 2014-12-31 | $0.11B | $0.05B | 47.62% |
| 2014-09-30 | $0.10B | $0.05B | 48.54% |
| 2014-06-30 | $0.10B | $0.05B | 49.00% |
| 2014-03-31 | $0.10B | $0.05B | 49.47% |
| 2013-12-31 | $0.09B | $0.05B | 50.00% |
| 2013-09-30 | $0.09B | $0.04B | 51.16% |
| 2013-06-30 | $0.08B | $0.04B | 51.81% |
| 2013-03-31 | $0.08B | $0.04B | 51.81% |
| 2012-12-31 | $0.08B | $0.04B | 51.81% |
| 2012-09-30 | $0.08B | $0.04B | 51.22% |
| 2012-06-30 | $0.08B | $0.04B | 50.62% |
| 2012-03-31 | $0.08B | $0.04B | 50.63% |
| 2011-12-31 | $0.08B | $0.04B | 51.28% |
| 2011-09-30 | $0.08B | $0.04B | 51.95% |
| 2011-06-30 | $0.08B | $0.04B | 51.32% |
| 2011-03-31 | $0.08B | $0.04B | 50.00% |
| 2010-12-31 | $0.09B | $0.04B | 48.89% |
| 2010-09-30 | $0.10B | $0.05B | 47.06% |
| 2010-06-30 | $0.12B | $0.05B | 46.09% |
| 2010-03-31 | $0.12B | $0.06B | 45.97% |
| 2009-12-31 | $0.13B | $0.06B | 45.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.014B | $0.057B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.877B | 24.14 |
| Stryker (SYK) | United States | $128.028B | 30.70 |
| Boston Scientific (BSX) | United States | $107.805B | 33.58 |
| Medtronic (MDT) | Ireland | $106.544B | 15.08 |
| EssilorLuxottica (ESLOY) | France | $97.060B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.204B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.949B | 30.46 |
| ResMed (RMD) | United States | $31.437B | 29.52 |
| Terumo (TRUMY) | Japan | $25.223B | 35.62 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.713B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $24.656B | 19.10 |
| Baxter (BAX) | United States | $20.501B | 14.95 |
| Insulet (PODD) | United States | $12.040B | 63.21 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.549B | 0.00 |
| Demant (WILYY) | Denmark | $10.525B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.693B | 22.92 |
| BellRing Brands (BRBR) | United States | $7.226B | 38.85 |
| Haemonetics (HAE) | United States | $4.670B | 23.88 |
| Lantheus Holdings (LNTH) | United States | $4.561B | 11.78 |
| Perrigo (PRGO) | Ireland | $4.426B | 12.66 |
| GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
| Prestige Consumer Healthcare (PBH) | United States | $3.563B | 16.84 |
| Envista Holdings (NVST) | United States | $3.382B | 12.86 |
| Green Thumb Industries (GTBIF) | United States | $3.229B | 102.33 |
| QuidelOrtho (QDEL) | United States | $2.712B | 9.84 |
| Neogen (NEOG) | United States | $2.671B | 25.69 |
| ICU Medical (ICUI) | United States | $2.386B | 17.80 |
| Verano Holdings (VRNOF) | United States | $2.161B | 0.00 |
| TG Therapeutics (TGTX) | United States | $2.111B | 683.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.061B | 0.00 |
| Owens & Minor (OMI) | United States | $1.895B | 18.19 |
| Agios Pharmaceuticals (AGIO) | United States | $1.845B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.491B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.455B | 48.00 |
| InMode (INMD) | Israel | $1.444B | 7.47 |
| National Vision Holdings (EYE) | United States | $1.364B | 42.49 |
| AdaptHealth (AHCO) | United States | $1.309B | 9.85 |
| AtriCure (ATRC) | United States | $1.167B | 0.00 |
| Warby Parker (WRBY) | United States | $1.163B | 0.00 |
| MacroGenics (MGNX) | United States | $0.925B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.857B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.795B | 0.00 |
| Evolus (EOLS) | United States | $0.737B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.676B | 14.65 |
| VAREX IMAGING (VREX) | United States | $0.660B | 14.25 |
| TerrAscend (TSNDF) | Canada | $0.635B | 0.00 |
| Quanterix (QTRX) | United States | $0.617B | 0.00 |
| Jin Medical (ZJYL) | China | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.503B | 0.00 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| ZimVie (ZIMV) | United States | $0.414B | 25.33 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.405B | 6.70 |
| Surmodics (SRDX) | United States | $0.366B | 39.52 |
| Zynex (ZYXI) | United States | $0.353B | 47.70 |
| Viemed Healthcare (VMD) | United States | $0.318B | 31.50 |
| Cerus (CERS) | United States | $0.309B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.263B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.71 |
| Organigram Holdings (OGI) | Canada | $0.219B | 0.00 |
| Veru (VERU) | United States | $0.198B | 0.00 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.171B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.166B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.165B | 83.00 |
| Quipt Home Medical (QIPT) | United States | $0.153B | 0.00 |
| InterCure (INCR) | Israel | $0.133B | 22.46 |
| FitLife Brands (FTLF) | United States | $0.128B | 20.55 |
| MariMed (MRMD) | United States | $0.122B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 8.55 |
| Allurion Technologies (ALUR) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.087B | 0.00 |
| Chimerix (CMRX) | United States | $0.084B | 0.00 |
| Safety Shot (SHOT) | United States | $0.075B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.062B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.47 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.66 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Flora Growth (FLGC) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.016B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |